Fol. Biol. 2009, 55, 187-191

https://doi.org/10.14712/fb2009055050187

Association of the eNOS 4a/b and -786T/C Polymormphisms with Coronary Artery Disease, Obesity and Diabetes Mellitus

Vladimír Kincl1, A. Vašků2, J. Meluzín1, R. Panovský1, J. Seménka1, L. Groch1

11st Department of Internal Medicine and Cardioangiology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic
2Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic

Received January 2009
Accepted June 2009

References

1. Alvarez, R., Gonzales, P., Batala, A., Reguero, J. R., IglesiasCubero, G., Hevia, S., Cortina, A., Merino, E., Gonzalez, I., Alvarez, V., Coto, E. (2001) Association between the NOS3 (-786T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 5, 43-48. <https://doi.org/10.1006/niox.2001.0351>
2. Bucala, R., Ritchlin, C., Winchester, R., Cerami, A. (1991) Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J. Exp. Med. 173, 569-574. <https://doi.org/10.1084/jem.173.3.569>
3. Casas, J. P., Bautista, L. E., Humpries, S. E., Hingorani, A. D. (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease. Circulation 109, 1359-1365. <https://doi.org/10.1161/01.CIR.0000121357.76910.A3>
4. Colombo, M. G., Paradossi, U., Andreassi, M. G., Botto, N., Manfredi, S., Masetti, S., Biagini, A., Clerico, A. (2003) Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin. Chem. 49, 389-395. <https://doi.org/10.1373/49.3.389>
5. Fatini, C., Sofi, F., Sticchi, E., Gensini, F., Gori, A. M., Fedi, S., Lapini, I., Rostagno, C., Comeglio, M., Brogi, D., Gensini, G., Abbate, R. (2004) Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am. Heart J. 147, 516-521. <https://doi.org/10.1016/j.ahj.2003.10.032>
6. Galanakis, E., Kofteridis, D., Stratigi, K., Petraki, E., Vazgiourakis, V., Fragouli, E., Mamoulakis, D., Boumpas, D. T., Goulielmos, G. N. (2008) Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population. Hum. Immunol. 69, 279-283. <https://doi.org/10.1016/j.humimm.2008.03.001>
7. Gardemann, A., Lohre, J., Cayci, S., Katz, N., Tillmanns, H., Haberbosch, W. (2002) The T allele of the missense Glu298Asp endothelial nitric oxide gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerosis risk profile. Atherosclerosis 160, 167-175. <https://doi.org/10.1016/S0021-9150(01)00554-8>
8. Garg, U. C., Hassid, A. (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophospate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83, 1774-1777. <https://doi.org/10.1172/JCI114081>
9. Hingorani, A. D. (2001) Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture. Atherosclerosis 154, 521-527. <https://doi.org/10.1016/S0021-9150(00)00699-7>
10. Hoffmann, I. S., Tavares-Mordwinkin, R., Castejon, A. M., Alfieri, A. B., Cubeddu, L. X. (2005) Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J. Hum. Hypertens. 19, 233-240. <https://doi.org/10.1038/sj.jhh.1001801>
11. Hwang, J. J., Tsai, C. T., Yeh, H. M., Chiang, F. T., Hsu, K. L., Tseng, C. D., Liau, C. S., Tseng, Y. Z., Lai, L. P. (2002) The 27-bp tandem repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene is not associated with coronary artery disease in a hospital-based Taiwanese population. Cardiology 97, 67-72. <https://doi.org/10.1159/000057674>
12. Jeerooburkhan, N., Jones, L. C., Bujac, S., Cooper, J. A., Miller, G. J., Vallance, P., Humphries, S. E., Hingorani, A. D. (2001) Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension 38, 1054-1061. <https://doi.org/10.1161/hy1101.092967>
13. Kutlu, B., Cardozo, A. K., Darville, M. I., Kruhoffer, M., Magnusson, N., Orntoft, T., Eizirik, D. L. (2003) Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52, 2701-2719. <https://doi.org/10.2337/diabetes.52.11.2701>
14. Lefer, A. M. (1997) Nitric oxide: nature’s naturally occurring leukocyte inhibitor. Circulation 95, 553-554. <https://doi.org/10.1161/01.CIR.95.3.553>
15. Loscalzo, J., Welch, G. (1995) Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis. 38, 87-104. <https://doi.org/10.1016/S0033-0620(05)80001-5>
16. Nakayama, T., Yasue, H., Yoshimura, M., Shimasaki, Y., Kugiyama, K., Ogawa, H., Motoyama, T., Saito, Y., Ogawa, Y., Miyamoto, Y., Nakao, K. (1999) T-786C mutation in the 5´-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99, 2864-2870. <https://doi.org/10.1161/01.CIR.99.22.2864>
17. Pieper, G. M. (1999) Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: Importance of disease duration. Diabetologia 42, 204-213. <https://doi.org/10.1007/s001250051140>
18. Radomski, M. W., Palmer, R. M. J., Moncada, S. (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2, 1057-1058. <https://doi.org/10.1016/S0140-6736(87)91481-4>
19. Rossi, G. P., Maiolino, G., Zanchetta, M., Sticchi, D., Pedon, L., Cesari, M., Montemurro, D., De Toni, R., Zavattiero, S., Pessina, A. C. (2006) The T-786C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high risk patients. J. Am. Coll. Cardiol. 48, 1166-1174. <https://doi.org/10.1016/j.jacc.2006.05.046>
20. Tsukada, T., Yokoyama, K., Arai, T., Takemoto, F., Hara, S., Yamada, A., Kawaguchi, Y., Hosoya, T., Igari, J. (1998) Evidence of association of the eNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Comun. 245, 190-193. <https://doi.org/10.1006/bbrc.1998.8267>
21. Wang, X. L., Sim, A. S., Badenhop, R. F., McCredie, R. M, Wilcken, D. E. L. (1996) A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 2, 41-45. <https://doi.org/10.1038/nm0196-41>
22. Wang, X. L., Mahaney, M. C., Sim, A. S., Wang, J., Blangero, J., Almasy, L., Badenhop, R. B., Wilcken, D. E. L. (1997) Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler. Thromb. Vasc. Biol. 17, 3147-3153. <https://doi.org/10.1161/01.ATV.17.11.3147>
23. Wang, X. L., Sim, A. S., Wang, M. X., Murrell, G. A. C., Trudinger, B., Wang, J. (2000) Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 471, 45-50. <https://doi.org/10.1016/S0014-5793(00)01356-9>
24. Yoon, Y., Song, J., Hong, S. H, Kim, J. Q. (2000) Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin. Chem. 46, 1626-1630. <https://doi.org/10.1093/clinchem/46.10.1626>
25. Yoshimura, M., Yasue, H., Nakayama, M., Shimasaki, Y., Ogawa, H., Kugiyama, K., Saito, Y., Miyamoto, Y., Ogawa, Y., Kaneshige, T., Hiramatsu, H., Yoshioka, T., Kamitani, S., Teraoka, H., Nakao, K. (2000) Genetic risk factors for coronary artery spasm: signigicance of endothelial nitric oxide synthase gene T-786C and missense Glu298Asp variants. J. Invest. Med. 48, 367-374.
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive